Notify me when Ph.D. WEI-WU HE files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| CASI | CASI Pharmaceuticals, Inc. | Ordinary Shares | 19% | $3,687,948 | 3,965,535 | 0% | WEI-WU HE, Ph.D. | 09 Jan 2026 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|